Last week’s announcement by the country’s drug price regulator doing away with a provision that permitted it to determine the price of drugs considered ‘non-essential’, was the culmination of a conflict between it and drug manufacturers. In July 2014, the National Pharmaceutical Pricing Authority (NPPA), the country’s nodal drug price determining body, came out with an order capping the price of 108 drugs not included in the National List of Essential Medicines (NLEM) which lists 652 formulations. This had drawn the ire of domestic and multinational manufacturers who went to court against the order.

Click Here To Read More